Warning
Lupin Pharmaceuticals Inc. Recalls Glucagon Emergency Kit for Low Blood Sugar
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0723-2026Drug / Pharmaceutical
Lupin Pharmaceuticals Inc. Recalls Glucagon Emergency Kit for Low Blood Sugar
Lupin Pharmaceuticals Inc. · Class II — Moderate Risk
Product Description
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
Reason for Recall
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide within the U.S.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class II FDA recall has been issued for a pharmaceutical product from Lupin Pharmaceuticals Inc., initiated on June 23, 2026. CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing. This recall covers 64,894 units, distributed nationwide. While not the highest severity, consumers should exercise caution and stop using the product until the recall is resolved.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.